Yue-Zhong Wu

<i>IDH1</i> and <i>IDH2</i> Gene Mutations Identify Novel Molecular Subsets Within De Novo Cytogenetically Normal Acute Myeloid Leukemia: A Cancer and Leukemia Group B Study

Guido Marcucci, Kati Maharry, Yue-Zhong Wu et al. · Journal of Clinical Oncology · 2010 · 764 citations · Full text

Medicine, Hematology, Oncology +17

Prognostic Significance of the European LeukemiaNet Standardized System for Reporting Cytogenetic and Molecular Alterations in Adults With Acute Myeloid Leukemia

Krzysztof Mrózek, Guido Marcucci, Deedra Nicolet et al. · Journal of Clinical Oncology · 2012 · 406 citations · Full text

Life Sciences, Hematology, Oncology +15

Favorable Prognostic Impact of <i>NPM1</i> Mutations in Older Patients With Cytogenetically Normal De Novo Acute Myeloid Leukemia and Associated Gene- and MicroRNA-Expression Signatures: A Cancer and Leukemia Group B Study

Heiko Becker, Guido Marcucci, Kati Maharry et al. · Journal of Clinical Oncology · 2009 · 339 citations · Full text

Medicine, Molecular Genetics, Oncology +17

<i>TET2</i> Mutations Improve the New European LeukemiaNet Risk Classification of Acute Myeloid Leukemia: A Cancer and Leukemia Group B Study

Klaus H. Metzeler, Kati Maharry, Michael D. Radmacher et al. · Journal of Clinical Oncology · 2011 · 320 citations · Full text

Medicine, Molecular Genetics, Oncology +17

ASXL1 mutations identify a high-risk subgroup of older patients with primary cytogenetically normal AML within the ELN Favorable genetic category

Klaus H. Metzeler, Heiko Becker, Kati Maharry et al. · Blood · 2011 · 277 citations · Full text

Life Sciences, Genetics, Molecular Genetics +16